Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway

Figure 1

Effects of cisplatin, cetuximab, and a combination of both on NPC cell growth. HNE1 and CNE2 cells were treated with the indicated concentrations of (a) cetuximab, (b) cisplatin, or (c) 1 µg/mL cisplatin and 250 µg/mL cetuximab for 48 h, and cell viability was determined by a CCK-8 assay. (d) The classic isobologram of HNE1 and CNE2 cells. , versus cisplatin treatment alone.

(a)

(b)

(c)

(d)